methadone has been researched along with AIDS Seroconversion in 157 studies
Methadone: A synthetic opioid that is used as the hydrochloride. It is an opioid analgesic that is primarily a mu-opioid agonist. It has actions and uses similar to those of MORPHINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1082-3)
methadone : A racemate comprising equimolar amounts of dextromethadone and levomethadone. It is a opioid analgesic which is used as a painkiller and as a substitute for heroin in the treatment of heroin addiction.
6-(dimethylamino)-4,4-diphenylheptan-3-one : A ketone that is heptan-3-one substituted by a dimethylamino group at position 6 and two phenyl groups at position 4.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To examine the long-term impact of methadone maintenance treatment (MMT) on mortality, re-incarceration and hepatitis C seroconversion in imprisoned male heroin users." | 9.11 | Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection. ( Dolan, KA; Kaldor, J; Shearer, J; White, B; Wodak, AD; Zhou, J, 2005) |
| "To study the efficacy of standard hepatitis B (HB) vaccination in methadone-maintained former intravenous drug users." | 7.70 | Methadone-maintained former heroin addicts, including those who are anti-HIV-1 seropositive, comply with and respond to hepatitis B vaccination. ( Bergasa, NV; Borg, L; Ho, A; Khuri, E; Kreek, MJ; Melia, D; Wells, A, 1999) |
| "We studied natural killer (NK) activity and lymphocyte subsets in 11 active parenteral heroin abusers, 11 long-term methadone-maintained former heroin abusers and 11 apparently healthy individuals." | 7.67 | Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients. ( Chiorazzi, N; Croxson, TS; Ghali, V; Kreek, MJ; Mercer, WD; Novick, DM; Ochshorn, M, 1989) |
| "Age, and the duration of opioid dependence showed a significant influence on cocaine positive urinalysis." | 5.31 | [Cocaine abuse in maintenance therapy with methadone in narcotic dependent patients]. ( Fischer, G; Kraigher, D; Ortner, R; Peternell, A; Schindler, S; Topitz, A, 2001) |
| "To examine the long-term impact of methadone maintenance treatment (MMT) on mortality, re-incarceration and hepatitis C seroconversion in imprisoned male heroin users." | 5.11 | Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection. ( Dolan, KA; Kaldor, J; Shearer, J; White, B; Wodak, AD; Zhou, J, 2005) |
| " Data on HIV and hepatitis C virus (HCV) infections, methadone dosage, and morphine in the urine were retrieved from patient files on the clinical premises, with permission of the participants." | 3.77 | Clinical characteristics and risk behavior as a function of HIV status among heroin users enrolled in methadone treatment in northern Taiwan. ( Chou, YC; Chuang, P; Huang, CW; Lee, TS; Liu, YL; Shen, HC; Shih, CY; Wang, BE; Wu, WH; Yen, MY, 2011) |
| " Additional factors associated with BMD decline were: postmenopausal status, lower BMI, and methadone use at the lumbar spine; postmenopausal status and hepatitis C seropositivity at the femoral neck; and postmenopausal status, age, smoking, and lower BMI at the total hip (all p<." | 3.77 | Prospective evaluation of bone mineral density among middle-aged HIV-infected and uninfected women: Association between methadone use and bone loss. ( Cohen, HW; Freeman, R; Santoro, N; Schoenbaum, EE; Sharma, A, 2011) |
| "To study the efficacy of standard hepatitis B (HB) vaccination in methadone-maintained former intravenous drug users." | 3.70 | Methadone-maintained former heroin addicts, including those who are anti-HIV-1 seropositive, comply with and respond to hepatitis B vaccination. ( Bergasa, NV; Borg, L; Ho, A; Khuri, E; Kreek, MJ; Melia, D; Wells, A, 1999) |
| " In the majority of cases (60%) death was deemed to be accidental and most were due to accidental drug overdoses, with methadone being the drug most commonly detected on toxicological analysis." | 3.69 | Deaths among drug abusers in south-east Scotland (1989-1994). ( Bentley, AJ; Busuttil, A, 1996) |
| "To determine the effects of human immunodeficiency virus (HIV) infection on pregnancy outcomes, we prospectively studied female intravenous drug users in a methadone program in New York City." | 3.67 | Prospective study of human immunodeficiency virus infection and pregnancy outcomes in intravenous drug users. ( Davenny, K; Feingold, AR; Friedland, GH; Klein, RS; Mayers, MM; Robertson, VJ; Rogers, MF; Schoenbaum, EE; Selwyn, PA; Shulman, JF, 1989) |
| "We studied natural killer (NK) activity and lymphocyte subsets in 11 active parenteral heroin abusers, 11 long-term methadone-maintained former heroin abusers and 11 apparently healthy individuals." | 3.67 | Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients. ( Chiorazzi, N; Croxson, TS; Ghali, V; Kreek, MJ; Mercer, WD; Novick, DM; Ochshorn, M, 1989) |
| " The average DAM dosage was 274." | 2.72 | Controlled trial of prescribed heroin in the treatment of opioid addiction. ( Carrasco, F; March, JC; Oviedo-Joekes, E; Perea-Milla, E, 2006) |
| "Antipyrine half-life was significantly reduced (12." | 2.69 | Effect of fusidic acid on the hepatic cytochrome P450 enzyme system. ( Barthel, B; Brockmeyer, NH; Reimann, G; Rockstroh, JK; Spatz, D, 1999) |
| "This paper on drug use and HIV/AIDS in China follows on from the column's May 2005 article on the description of the first methadone maintenance clinic in Beijing." | 2.43 | Drug use and HIV/AIDS in China. ( Lian, Z; Liu, Z; Zhao, C, 2006) |
| "For the near term, control of the AIDS epidemic depends entirely upon altering the human behavior which results in HIV transmission." | 2.38 | What do we really know about AIDS control? ( Judson, FN, 1989) |
| "The Fagerström test was used to measure nicotine dependence (FTND)." | 1.46 | Factors associated with nicotine dependence during methadone maintenance treatment: findings from a multisite survey in Vietnam. ( Do, HP; Dunne, MP; Latkin, CA; Le, GT; Le, HT; Ngo, C; Nguyen, CT; Nguyen, LH; Nguyen, LK; Phan, HTT; Thi Nguyen, HL; Thi Nguyen, NP; Tran, BX; Tran, TD; Vu, TMT, 2017) |
| " Dosage increase(26." | 1.43 | [Overdose of heroin and influencing factors in intravenous drug users in parts of Yunnan]. ( Cao, XB; Luo, W; Wu, ZY; Zhang, B; Zhou, Y, 2016) |
| " In a subanalysis, we observed a dose-response relationship between increasing MMT dose and ART adherence (AOR = 1." | 1.42 | Dose-response relationship between methadone dose and adherence to antiretroviral therapy among HIV-positive people who use illicit opioids. ( Ahamad, K; Dobrer, S; Dong, H; Kerr, T; Lappalainen, L; Milloy, MJ; Montaner, J; Nolan, S; Puscas, C; Wood, E, 2015) |
| "Heroin addicts were enrolled based on their fulfillment to eligibility criteria and provision of informed consent." | 1.39 | Referring heroin users from compulsory detoxification centers to community methadone maintenance treatment: a comparison of three models. ( Comulada, S; Duan, S; Liu, E; McGoogan, JM; Wu, LT; Wu, Z; Yan, L, 2013) |
| "Methadone maintenance treatment (MMT) is efficacious in reducing drug use that may improve HIV/AIDS care and treatment outcomes." | 1.38 | Cost-effectiveness of methadone maintenance treatment for HIV-positive drug users in Vietnam. ( Do, NT; Duong, AT; Houston, S; Jacobs, P; Mills, S; Nguyen, LT; Ohinmaa, A; Tran, BX, 2012) |
| " Data on methadone dosage at each follow-up interview and the duration of retention in the MMT program were also collected." | 1.38 | Predictors of the severity of depressive symptoms among intravenous heroin users receiving methadone maintenance treatment in Taiwan: an 18-month follow-up study. ( Chang, HC; Chung, KS; Wang, PW; Wu, HC; Yeh, YC; Yen, CF; Yen, CN, 2012) |
| "Dose, type of drug abuse, age and HIV status were related to the period of retention." | 1.35 | [Study on the time of retention and related influencing factors of patients receiving methadone maintenance treatment in Hunan province]. ( Chen, MS; Li, XL; Ou, QY; Sun, ZQ; Tan, HZ; Zhang, H, 2009) |
| "Eight HIV seroconversions were found among 1153 clients during 12 months." | 1.34 | Effectiveness of first eight methadone maintenance treatment clinics in China. ( Hao, Y; Li, J; Luo, W; Mi, G; Pang, L; Rou, K; Wang, C; Wu, Z, 2007) |
| "Clinicians should evaluate substance use, participation in methadone maintenance programs, and the use of psychotherapeutic medications and consider the neuroendocrinologic effects of these medications as a potential cause of menstrual disruptions." | 1.32 | Substance use and psychotherapeutic medications: a likely contributor to menstrual disorders in women who are seropositive for human immunodeficiency virus. ( Cohen, M; Cu-Uvin, S; Greenblatt, R; Gurtman, A; Harlow, SD; Khalsa, A; Klein, RS; Lin, X; Minkoff, H; Ohmit, SE; Schuman, P; Young, MA, 2003) |
| "Age, and the duration of opioid dependence showed a significant influence on cocaine positive urinalysis." | 1.31 | [Cocaine abuse in maintenance therapy with methadone in narcotic dependent patients]. ( Fischer, G; Kraigher, D; Ortner, R; Peternell, A; Schindler, S; Topitz, A, 2001) |
| " 5,510 +/- 237 microg/L), or terminal elimination half-life (t 1/2; 55." | 1.31 | The pharmacokinetics of methadone following co-administration with a lamivudine/zidovudine combination tablet in opiate-dependent subjects. ( Andrews, L; Friedland, GH; Jatlow, P; Lane, B; McCance-Katz, EF; Mitchell, SM; Rainey, PM; Snidow, JW, 2002) |
| "Among 385 IDUs seen twice, the HIV seroconversion rate was 0." | 1.30 | Who uses needle exchange? A study of injection drug users in treatment in San Francisco, 1989-1990. ( Hahn, JA; Moss, AR; Vranizan, KM, 1997) |
| "Working from the AIDS risk reduction model and other theories of behavior change, we tested psychosocial antecedents of needle/syringe disinfection by 136 injection drug users." | 1.30 | Psychosocial antecedents of needle/syringe disinfection by drug users: a theory-based prospective analysis. ( Anglin, MD; Longshore, D; Stein, JA, 1997) |
| "Using the 1993 clinical definition of AIDS, we found that the hazard ratio (HR) of progression to AIDS declined for enrollees over time in comparison with the referent group of persons enrolled in 1986-1987." | 1.30 | Temporal trends in the progression of human immunodeficiency virus disease in a cohort of drug users. ( Buono, D; Chang, CJ; Gourevitch, MN; Klein, RS; Schoenbaum, EE; Webber, MP, 1998) |
| "6, compared with no change] and increase in methadone dosage (RR, 0." | 1.30 | Methadone maintenance treatment modalities in relation to incidence of HIV: results of the Amsterdam cohort study. ( Coutinho, RA; Langendam, MW; van Ameijden, EJ; van Brussel, GH, 1999) |
| "We evaluated the medical histories, drug abuse patterns, sexual behaviors, serological studies for syphilis and hepatitis B infection and other laboratory studies in 1780 patients enrolled in New York City drug treatment clinics in 1987." | 1.29 | Medical disorders in a cohort of New York city drug abusers: much more than HIV disease. ( Ajuluchukwu, DC; Bailey, J; Brown, LS; Hickson, MJ, 1993) |
| "Heroin (88%) was the most popular drug." | 1.29 | [The clinical and epidemiological aspects of the neonatal abstinence syndrome]. ( Arrate-Zugazabeitia, JK; Delgado-Rubio, A; Echaniz-Urcelay, I; Fortea-Jimeno, E; Pérez-Bescos, L; Saitua-Iturriaga, G, 1993) |
| "Methadone users were compared to nonmethadone users for absolute and percentage counts of CD4, CD8, and activated T lymphocytes; CD4/CD8 ratio; an HIV symptom check list; and medical staging." | 1.29 | The effect of methadone on immunological parameters among HIV-positive and HIV-negative drug users. ( Carballo-Diéguez, A; el Sadr, W; Goetz, R; Gorman, J; Sahs, J; Sorell, S, 1994) |
| "The overall annual HIV seroconversion rate shifted only slightly from 13% in the first study period (1984 to mid-1986) to 11% in the second period (mid-1986 to end 1988)." | 1.29 | Methadone treatment and risk of HIV infection in drug users without legal access to clean injection equipment. ( Martin, J; Meystre-Agustoni, G; Wietlisbach, V, 1995) |
| "Counselors of HIV-afflicted substance abusers not only must apply counseling strategies directed toward curbing drug use, but also are called upon to assess suicide risk, attend to the promotion of social support, treat adverse affective reactions, and respond to spiritual and existential concerns." | 1.28 | A cognitive-existential analysis of counselor responses to HIV-positive substance misusers in an outpatient methadone program and a residential therapeutic community. ( Capone, CT; Condren, R; DeRovira, N; Katowsky, K; Melchionda, R; Peterson, M, 1992) |
| "Clonidine has been used to assist opiate detoxification in the past 10 years." | 1.28 | Two cases of clonidine abuse/dependence in methadone-maintained patients. ( Lauzon, P, 1992) |
| "Methadone therapy was associated with substantial reductions in heroin use and some reduction in cocaine use, but 24% of cocaine users receiving methadone began or increased cocaine injection after entry into treatment." | 1.28 | Cocaine use and HIV infection in intravenous drug users in San Francisco. ( Bacchetti, P; Brodie, B; Chaisson, RE; Moss, AR; Osmond, D; Sande, MA, 1989) |
| "Of the 7 patients who developed AIDS or ARC, 4 were tested for both antibodies and T-cell ratios: all 4 were seropositive and had low ratios." | 1.27 | Serologic, immunologic, and clinical features of parenteral drug users from contrasting populations. ( Bodner, AJ; Emeson, E; Friedland, G; Harris, C; Moll, B; Shine, D; Small, CB; Spigland, I; Weiss, SH, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (8.92) | 18.7374 |
| 1990's | 74 (47.13) | 18.2507 |
| 2000's | 35 (22.29) | 29.6817 |
| 2010's | 33 (21.02) | 24.3611 |
| 2020's | 1 (0.64) | 2.80 |
| Authors | Studies |
|---|---|
| Jiménez-Treviño, L | 1 |
| Martínez-Cao, C | 1 |
| Sánchez-Lasheras, F | 1 |
| Iglesias, C | 1 |
| Antuña, MJ | 1 |
| Riera, L | 1 |
| Sáiz-Martínez, PA | 1 |
| Bobes, J | 1 |
| Do, HP | 1 |
| Nguyen, LH | 2 |
| Thi Nguyen, NP | 1 |
| Ngo, C | 1 |
| Thi Nguyen, HL | 1 |
| Le, GT | 1 |
| Nguyen, LK | 1 |
| Nguyen, CT | 2 |
| Tran, BX | 5 |
| Le, HT | 1 |
| Vu, TMT | 1 |
| Phan, HTT | 1 |
| Tran, TD | 1 |
| Latkin, CA | 3 |
| Dunne, MP | 1 |
| Kwan, TH | 1 |
| Wong, NS | 1 |
| Lee, SS | 1 |
| Seewald, R | 1 |
| Bruce, RD | 1 |
| Elam, R | 1 |
| Tio, R | 1 |
| Lorenz, S | 1 |
| Friedmann, P | 1 |
| Rabin, D | 1 |
| Garger, YB | 1 |
| Bonilla, V | 1 |
| Perlman, DC | 1 |
| Yan, L | 1 |
| Liu, E | 1 |
| McGoogan, JM | 2 |
| Duan, S | 4 |
| Wu, LT | 1 |
| Comulada, S | 1 |
| Wu, Z | 7 |
| Cui, N | 1 |
| Cao, XB | 2 |
| Wang, CH | 1 |
| Luo, W | 7 |
| Pang, L | 4 |
| Rou, KM | 2 |
| Wu, ZY | 3 |
| Dominy, SS | 1 |
| Brown, JN | 1 |
| Ryder, MI | 1 |
| Gritsenko, M | 1 |
| Jacobs, JM | 1 |
| Smith, RD | 1 |
| Jiang, H | 2 |
| Cao, X | 4 |
| Wang, C | 5 |
| Li, J | 3 |
| Rou, K | 6 |
| Zhang, B | 4 |
| Fang, Y | 1 |
| Li, C | 1 |
| Zhao, Y | 2 |
| Shi, CX | 1 |
| Zhang, F | 1 |
| Uhlmann, S | 1 |
| Milloy, MJ | 3 |
| Ahamad, K | 2 |
| Nguyen, P | 1 |
| Kerr, T | 4 |
| Wood, E | 4 |
| Richardson, L | 1 |
| Lappalainen, L | 1 |
| Nolan, S | 1 |
| Dobrer, S | 1 |
| Puscas, C | 1 |
| Montaner, J | 3 |
| Dong, H | 2 |
| Qian, X | 1 |
| Min, X | 1 |
| Tang, R | 1 |
| Bach, P | 1 |
| Guillemi, S | 2 |
| Nong, VM | 1 |
| Phan, HT | 1 |
| Zhou, Y | 1 |
| Barry, DT | 1 |
| Cutter, CJ | 1 |
| Beitel, M | 2 |
| Kerns, RD | 1 |
| Liong, C | 1 |
| Schottenfeld, RS | 2 |
| Havens, JR | 1 |
| Pu, M | 1 |
| Cornelius, LJ | 1 |
| Bishai, D | 1 |
| Huettner, S | 1 |
| Rapp, C | 1 |
| Ricketts, EP | 1 |
| Lloyd, JJ | 1 |
| Strathdee, SA | 2 |
| Ryder, N | 1 |
| Cullen, W | 1 |
| Barry, J | 1 |
| Bury, G | 1 |
| Keenan, E | 1 |
| Smyth, BP | 1 |
| Li, XL | 1 |
| Tan, HZ | 1 |
| Sun, ZQ | 1 |
| Zhang, H | 1 |
| Chen, MS | 1 |
| Ou, QY | 1 |
| Afriandi, I | 1 |
| Siregar, AY | 1 |
| Meheus, F | 1 |
| Hidayat, T | 1 |
| van der Ven, A | 1 |
| van Crevel, R | 1 |
| Baltussen, R | 1 |
| Pettes, T | 1 |
| Lai, C | 1 |
| Williams, CT | 1 |
| Liu, W | 1 |
| Levy, JA | 1 |
| Chawarski, MC | 1 |
| Zhou, W | 1 |
| Berg, KM | 2 |
| Wilson, IB | 1 |
| Li, X | 2 |
| Arnsten, JH | 2 |
| Lee, TS | 1 |
| Shen, HC | 1 |
| Wu, WH | 1 |
| Huang, CW | 1 |
| Yen, MY | 1 |
| Wang, BE | 1 |
| Chuang, P | 1 |
| Shih, CY | 1 |
| Chou, YC | 1 |
| Liu, YL | 1 |
| Gervasoni, JP | 1 |
| Balthasar, H | 1 |
| Huissoud, T | 2 |
| Jeannin, A | 1 |
| Dubois-Arber, F | 1 |
| Ohinmaa, A | 3 |
| Duong, AT | 3 |
| Do, NT | 2 |
| Nguyen, LT | 3 |
| Nguyen, QC | 1 |
| Mills, S | 3 |
| Jacobs, P | 3 |
| Houston, S | 3 |
| Wang, PW | 1 |
| Wu, HC | 1 |
| Yen, CN | 1 |
| Yeh, YC | 1 |
| Chung, KS | 1 |
| Chang, HC | 1 |
| Yen, CF | 1 |
| Sharma, A | 1 |
| Cohen, HW | 1 |
| Freeman, R | 1 |
| Santoro, N | 1 |
| Schoenbaum, EE | 6 |
| Xing, Y | 1 |
| Sun, J | 1 |
| Cao, W | 1 |
| Lee, L | 1 |
| Guo, H | 1 |
| Li, H | 1 |
| Cooperman, NA | 1 |
| Heo, M | 1 |
| Litwin, AH | 1 |
| Nahvi, S | 1 |
| Yang, YC | 1 |
| Han, J | 1 |
| Yang, SS | 1 |
| Yang, YB | 1 |
| Long, YC | 1 |
| Li, GQ | 1 |
| Yin, JS | 1 |
| Xiang, LF | 1 |
| Ye, RH | 1 |
| Gao, J | 1 |
| Tang, RH | 1 |
| He, N | 1 |
| Vu, PX | 1 |
| Sánchez, GV | 1 |
| Llibre, JM | 1 |
| Torrens, M | 3 |
| Sanvisens, A | 1 |
| Mateu, G | 1 |
| Knobel, H | 1 |
| Langohr, K | 1 |
| Santos, JR | 1 |
| Muga, R | 1 |
| Zhang, Z | 1 |
| Poundstone, KE | 1 |
| Yin, W | 1 |
| Pérez Pons, JC | 1 |
| Jornet Montaña, S | 1 |
| Bonet Esteve, A | 1 |
| Harlow, SD | 1 |
| Cohen, M | 1 |
| Ohmit, SE | 1 |
| Schuman, P | 1 |
| Cu-Uvin, S | 1 |
| Lin, X | 1 |
| Greenblatt, R | 1 |
| Gurtman, A | 1 |
| Khalsa, A | 1 |
| Minkoff, H | 1 |
| Young, MA | 1 |
| Klein, RS | 4 |
| Avants, SK | 4 |
| Marcotte, D | 1 |
| Arnold, R | 1 |
| Margolin, A | 4 |
| Turner, BJ | 2 |
| Laine, C | 1 |
| Yang, CP | 1 |
| Hauck, WW | 1 |
| Chan, AC | 1 |
| Palepu, A | 1 |
| Guh, DP | 1 |
| Sun, H | 1 |
| Schechter, MT | 1 |
| O'Shaughnessy, MV | 1 |
| Anis, AH | 1 |
| Puigdollers, E | 1 |
| Domingo-Salvany, A | 1 |
| Brugal, MT | 1 |
| Alvarós, J | 1 |
| Castillo, C | 2 |
| Magrí, N | 1 |
| Martín, S | 1 |
| Vázquez, JM | 1 |
| Walley, AY | 1 |
| White, MC | 1 |
| Kushel, MB | 1 |
| Song, YS | 1 |
| Tulsky, JP | 1 |
| Pelet, A | 1 |
| Doll, S | 1 |
| Resplendino, J | 1 |
| Besson, J | 1 |
| Favrat, B | 1 |
| Dolan, KA | 1 |
| Shearer, J | 1 |
| White, B | 1 |
| Zhou, J | 1 |
| Kaldor, J | 1 |
| Wodak, AD | 1 |
| Lejeune, C | 1 |
| Simmat-Durand, L | 1 |
| Gourarier, L | 1 |
| Aubisson, S | 1 |
| Liu, Z | 1 |
| Lian, Z | 1 |
| Zhao, C | 1 |
| Fontdevila, J | 1 |
| El-Bassel, N | 2 |
| Gilbert, L | 1 |
| Wu, E | 1 |
| Chang, M | 1 |
| Rodríguez Salgado, D | 1 |
| Rodríguez Alvarez, M | 1 |
| Seoane Pesqueira, G | 1 |
| March, JC | 1 |
| Oviedo-Joekes, E | 1 |
| Perea-Milla, E | 1 |
| Carrasco, F | 1 |
| Préau, M | 1 |
| Protopopescu, C | 1 |
| Spire, B | 1 |
| Dellamonica, P | 1 |
| Poizot-Martin, I | 1 |
| Villes, V | 1 |
| Carrieri, MP | 1 |
| Inciardi, JA | 1 |
| Surratt, HL | 1 |
| Kurtz, SP | 1 |
| Cicero, TJ | 1 |
| Gourevitch, MN | 4 |
| Chatterji, P | 1 |
| Deb, N | 1 |
| Edwards, JW | 1 |
| Fisher, DG | 1 |
| Johnson, ME | 1 |
| Reynolds, GL | 1 |
| Redpath, DP | 1 |
| Swaminathan, S | 1 |
| Howard, AA | 1 |
| Lo, Y | 1 |
| Cofrancesco, J | 1 |
| Brown, TT | 1 |
| Luo, RF | 1 |
| John, M | 1 |
| Stewart, KJ | 1 |
| Dobs, AS | 1 |
| Schuman-Olivier, Z | 1 |
| Arnold, RM | 1 |
| Fulwiler, CE | 1 |
| Hao, Y | 1 |
| Mi, G | 1 |
| Wietlisbach, V | 1 |
| Meystre-Agustoni, G | 1 |
| Martin, J | 1 |
| Wodak, A | 3 |
| Capelhorn, J | 1 |
| Crofts, N | 2 |
| Bertschy, G | 1 |
| Katz, SM | 1 |
| Galanter, M | 1 |
| Lifshutz, H | 1 |
| Maslansky, R | 1 |
| Baker, A | 1 |
| Kochan, N | 1 |
| Dixon, J | 1 |
| Heather, N | 1 |
| Wall, TL | 1 |
| Sorensen, JL | 1 |
| Batki, SL | 1 |
| Delucchi, KL | 1 |
| London, JA | 1 |
| Chesney, MA | 1 |
| Kitayaporn, D | 1 |
| Uneklabh, C | 1 |
| Weniger, BG | 1 |
| Lohsomboon, P | 1 |
| Kaewkungwal, J | 1 |
| Morgan, WM | 1 |
| Uneklabh, T | 1 |
| Pivnick, A | 1 |
| Farrell, M | 1 |
| Carpentier, J | 1 |
| Bloch-Lainé, JF | 1 |
| Hefez, S | 1 |
| Ingold, FR | 1 |
| Lowenstein, W | 1 |
| Haas, C | 1 |
| Durand, H | 1 |
| Carballo-Diéguez, A | 1 |
| Sahs, J | 1 |
| Goetz, R | 1 |
| el Sadr, W | 1 |
| Sorell, S | 1 |
| Gorman, J | 1 |
| Pérez-Bescos, L | 1 |
| Arrate-Zugazabeitia, JK | 1 |
| Fortea-Jimeno, E | 1 |
| Echaniz-Urcelay, I | 1 |
| Saitua-Iturriaga, G | 1 |
| Delgado-Rubio, A | 1 |
| Silberstein, CH | 1 |
| O'Dowd, MA | 2 |
| Chartock, P | 1 |
| Friedland, G | 2 |
| Hartel, D | 1 |
| McKegney, FP | 2 |
| McLachlan, C | 1 |
| Crowe, S | 1 |
| Di Franco, MJ | 1 |
| Marlink, R | 1 |
| Hunter, DJ | 1 |
| Tosteson, T | 1 |
| Mayer, K | 1 |
| Essex, M | 1 |
| Oertle, D | 1 |
| Edelmann, R | 1 |
| Ostewalder, J | 1 |
| Vernazza, PL | 1 |
| Galeazzi, RL | 1 |
| Bux, DA | 1 |
| Iguchi, MY | 1 |
| Lidz, V | 1 |
| Baxter, RC | 1 |
| Platt, JJ | 1 |
| Friedman, SR | 1 |
| Des Jarlais, DC | 1 |
| Ajuluchukwu, DC | 2 |
| Brown, LS | 6 |
| Crummey, FC | 2 |
| Foster, KF | 1 |
| Ismail, YI | 1 |
| Siddiqui, N | 1 |
| Hickson, MJ | 1 |
| Bailey, J | 2 |
| Sawyer, RC | 1 |
| Hickson, M | 1 |
| Lee, P | 1 |
| McNair, D | 1 |
| Rawls, J | 1 |
| Skinner, A | 1 |
| Senay, EC | 1 |
| Barthwell, AG | 1 |
| Marks, R | 1 |
| Bokos, P | 1 |
| Gillman, D | 1 |
| White, R | 1 |
| Rössler, H | 1 |
| Battista, HJ | 1 |
| Deisenhammer, F | 1 |
| Günther, V | 1 |
| Pohl, P | 1 |
| Prokop, L | 1 |
| Riemer, Y | 1 |
| Handelsman, L | 2 |
| Song, IS | 1 |
| Losonczy, M | 1 |
| Park, S | 1 |
| Jacobson, J | 2 |
| Wiener, J | 2 |
| Aronson, M | 2 |
| Blank, JH | 1 |
| Pérez-Solá, V | 1 |
| Wimbush, J | 1 |
| Amicarelli, A | 1 |
| Stein, MD | 1 |
| Bentley, AJ | 1 |
| Busuttil, A | 1 |
| Herman, M | 1 |
| Greenwood, J | 2 |
| Zealley, H | 1 |
| Gorman, D | 1 |
| Fineron, P | 1 |
| Squires, T | 1 |
| Hahn, JA | 1 |
| Vranizan, KM | 1 |
| Moss, AR | 2 |
| Longshore, D | 1 |
| Stein, JA | 1 |
| Anglin, MD | 2 |
| Salter, A | 1 |
| Solomon, PJ | 1 |
| DePhilippis, D | 1 |
| Kosten, TR | 1 |
| Webber, MP | 1 |
| Buono, D | 1 |
| Chang, CJ | 1 |
| Grella, CE | 1 |
| Campos, M | 1 |
| Stenbacka, M | 1 |
| Leifman, A | 1 |
| Romelsjö, A | 2 |
| Fugelstad, A | 1 |
| Agren, G | 1 |
| Beauverie, P | 1 |
| Taburet, AM | 2 |
| Dessalles, MC | 2 |
| Furlan, V | 2 |
| Touzeau, D | 1 |
| Gaughwin, M | 1 |
| Solomon, P | 1 |
| Ali, R | 1 |
| Cooper, DK | 1 |
| Chen, DR | 1 |
| Schilling, RF | 1 |
| Hafi, A | 1 |
| Bouchez, J | 1 |
| Charpentier, B | 1 |
| Gamaleya, N | 1 |
| Dmitrieva, I | 1 |
| Borg, S | 1 |
| Ericcson, N | 1 |
| van Ameijden, EJ | 2 |
| Krol, A | 1 |
| Vlahov, D | 2 |
| Flynn, C | 1 |
| van Haastrecht, HJ | 1 |
| Coutinho, RA | 3 |
| Snyder, DC | 1 |
| Paz, EA | 1 |
| Mohle-Boetani, JC | 1 |
| Fallstad, R | 1 |
| Black, RL | 1 |
| Chin, DP | 1 |
| Dittert, S | 1 |
| Naber, D | 1 |
| Soyka, M | 1 |
| Langendam, MW | 1 |
| van Brussel, GH | 1 |
| Porter, J | 1 |
| Reimann, G | 1 |
| Barthel, B | 1 |
| Rockstroh, JK | 1 |
| Spatz, D | 1 |
| Brockmeyer, NH | 1 |
| Borg, L | 1 |
| Khuri, E | 1 |
| Wells, A | 1 |
| Melia, D | 1 |
| Bergasa, NV | 1 |
| Ho, A | 1 |
| Kreek, MJ | 2 |
| Zule, WA | 1 |
| Desmond, DP | 1 |
| Ebert, FW | 1 |
| Shah, NG | 1 |
| Celentano, DD | 1 |
| Stambolis, V | 1 |
| Johnson, L | 1 |
| Nelson, KE | 1 |
| Lollis, CM | 1 |
| Strothers, HS | 1 |
| Chitwood, DD | 1 |
| McGhee, M | 1 |
| Turrina, C | 1 |
| Fiorazzo, A | 1 |
| Turano, A | 1 |
| Cacciani, P | 1 |
| Regini, C | 1 |
| Castelli, F | 1 |
| Sacchetti, E | 1 |
| Warburton, LA | 1 |
| Ortner, R | 1 |
| Peternell, A | 1 |
| Kraigher, D | 1 |
| Schindler, S | 1 |
| Topitz, A | 1 |
| Fischer, G | 1 |
| Rainey, PM | 1 |
| Friedland, GH | 3 |
| Snidow, JW | 1 |
| McCance-Katz, EF | 1 |
| Mitchell, SM | 1 |
| Andrews, L | 1 |
| Lane, B | 1 |
| Jatlow, P | 1 |
| Byrne, A | 1 |
| Hallinan, R | 1 |
| Hartgers, C | 1 |
| van den Hoek, A | 1 |
| Krijnen, P | 1 |
| Williams, AB | 1 |
| McNelly, EA | 1 |
| Williams, AE | 1 |
| D'Aquila, RT | 1 |
| Capone, CT | 1 |
| Melchionda, R | 1 |
| DeRovira, N | 1 |
| Katowsky, K | 1 |
| Condren, R | 1 |
| Peterson, M | 1 |
| Confalonieri, F | 1 |
| Cruccu, V | 1 |
| Villa, A | 1 |
| Siddiqui, NS | 1 |
| Phillips, RY | 1 |
| Vargas, O | 1 |
| Makuch, RW | 1 |
| Horvath, T | 1 |
| Schroeder, M | 1 |
| Peterson, A | 1 |
| Holloway, K | 1 |
| Ness, R | 1 |
| Herman, S | 1 |
| Lauzon, P | 1 |
| Waal, H | 1 |
| Knutsen, T | 1 |
| Welle-Strand, G | 1 |
| Klimas, NG | 2 |
| Blaney, NT | 2 |
| Morgan, RO | 1 |
| Chitwood, D | 2 |
| Milles, K | 2 |
| Lee, H | 1 |
| Fletcher, MA | 2 |
| Sundby, P | 1 |
| Maas, U | 1 |
| Kattner, E | 1 |
| Koch, S | 1 |
| Schfer, A | 1 |
| Obladen, M | 1 |
| Bell, J | 2 |
| Fernandes, D | 1 |
| Batey, R | 2 |
| Huber-Stemich, F | 1 |
| Haas, H | 1 |
| Selwyn, PA | 2 |
| Iezza, A | 1 |
| Novick, DM | 2 |
| Joseph, H | 1 |
| Croxson, TS | 2 |
| Salsitz, EA | 1 |
| Wang, G | 1 |
| Richman, BL | 1 |
| Poretsky, L | 1 |
| Keefe, JB | 1 |
| Whimbey, E | 1 |
| Morgan, R | 1 |
| Page, JB | 1 |
| Henriksson, S | 1 |
| Magura, S | 1 |
| Shapiro, JL | 1 |
| Grossman, JI | 1 |
| Siddiqi, Q | 1 |
| Lipton, DS | 1 |
| Amann, KR | 1 |
| Koger, J | 1 |
| Gehan, K | 1 |
| Feiner, C | 1 |
| Selwyn, P | 1 |
| Drucker, E | 1 |
| Nemoto, T | 2 |
| Foster, K | 2 |
| Chu, A | 2 |
| Weiss, SH | 2 |
| Peterson, PK | 1 |
| Gekker, G | 1 |
| Brummitt, C | 1 |
| Pentel, P | 1 |
| Bullock, M | 1 |
| Simpson, M | 1 |
| Hitt, J | 1 |
| Sharp, B | 1 |
| Primm, BJ | 1 |
| Judson, FN | 1 |
| Ochshorn, M | 1 |
| Ghali, V | 1 |
| Mercer, WD | 1 |
| Chiorazzi, N | 1 |
| Dwyer, D | 1 |
| Sanders, F | 1 |
| Patterson, T | 1 |
| Howard, R | 1 |
| Downie, J | 1 |
| Packham, DR | 1 |
| Cunningham, AL | 1 |
| Curtis, JL | 1 |
| Baker, SN | 1 |
| Foster, RE | 1 |
| Khanyile, CS | 1 |
| Wilkins, R | 1 |
| Chaisson, RE | 1 |
| Bacchetti, P | 1 |
| Osmond, D | 1 |
| Brodie, B | 1 |
| Sande, MA | 1 |
| Davenny, K | 1 |
| Robertson, VJ | 1 |
| Feingold, AR | 1 |
| Shulman, JF | 1 |
| Mayers, MM | 1 |
| Rogers, MF | 1 |
| Seligman, PJ | 1 |
| Campbell, RJ | 1 |
| Keeler, GP | 1 |
| Halpin, TJ | 1 |
| Shine, D | 1 |
| Moll, B | 1 |
| Emeson, E | 1 |
| Spigland, I | 1 |
| Harris, C | 1 |
| Small, CB | 1 |
| Bodner, AJ | 1 |
| Weinberg, DS | 1 |
| Murray, HW | 1 |
| Fuchs, WJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Chronic Pain and Opioid Dependence Assessment and Treatment[NCT00727675] | 15 participants (Actual) | Interventional | 2008-08-31 | Completed | |||
| Clinical Trial of Integrated Treatment for Pain and Opioid Dependence[NCT00634803] | Phase 1/Phase 2 | 90 participants (Actual) | Interventional | 2009-09-30 | Completed | ||
| Efficacy of Drug and Risk Behavior Counseling Intervention Among Injecting Drug Users at Opioid Substitution Treatment[NCT03721380] | 118 participants (Actual) | Interventional | 2012-05-14 | Completed | |||
| The Behavioral Activation for Chinese Substance Users (C-BA) Research Protocol[NCT03705143] | 90 participants (Actual) | Interventional | 2018-06-04 | Completed | |||
| Improving Self-Management of Chronic Conditions Among Homeless Persons: a Community-Based Participatory Approach Using Text Messaging[NCT03034993] | 64 participants (Actual) | Interventional | 2017-07-21 | Completed | |||
| A Randomized Controlled Trial of an Antiretroviral Treatment Adherence Intervention for HIV+ African Americans[NCT03331978] | 306 participants (Actual) | Interventional | 2018-01-23 | Completed | |||
| Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in Men[NCT04772469] | 1,509 participants (Actual) | Interventional | 2021-03-22 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
"Reduced illicit opioid use is defined as the number of documented opioid negative urine tests in each of the time periods.This measures the reduction in illicit opioid use - more opioid-negative tests means greater reductions in illicit opioid use. The highest possible score is 4- which would indicate 4 negative urine tests during the assessment period. Originally titled Reduced illicit opioid use and the timeframe was listed as 16 weeks." (NCT00634803)
Timeframe: 3 Months
| Intervention | opioid negative urine tests (Mean) | |||
|---|---|---|---|---|
| Intake/Induction | Month 1 | Month 2 | Month 3 | |
| CBT for POD | 0.67 | 2.67 | 2.96 | 2.80 |
| Educational Counseling for POD | 0.67 | 2.80 | 3.30 | 3.25 |
| Physician Management | 0.55 | 2.48 | 2.56 | 2.04 |
Pain intensity comprises the average of 4 items related to current pain and past-week average pain, pain at its worst, and pain at its least. Pain intensity is scored on 0-10 scale (average score ranges from 0-10), where higher scores indicate higher pain intensity.Originally labeled as Pain Reduction at 16 weeks- 3 months was the correct timeframe. (NCT00634803)
Timeframe: 3 months
| Intervention | units on a scale (Mean) | |||
|---|---|---|---|---|
| Intake/Induction | Month 1 | Month 2 | Month 3 | |
| CBT for POD | 5.43 | 4.75 | 4.79 | 4.41 |
| Educational Counseling for POD | 5.92 | 5.02 | 4.98 | 4.62 |
| Physician Management | 5.28 | 4.53 | 4.72 | 4.84 |
Pain interference comprises the average of 7 items related to past-week pain-related interference in general activity, walking, work, mood, enjoyment of life, relations with others, and sleep. Each item is scored on a 0-10 scale (averaged 0-10), where higher scores indicate higher pain interference. (NCT00634803)
Timeframe: 3 Months
| Intervention | units on a scale (Mean) | |||
|---|---|---|---|---|
| Intake/Induction | Month 1 | Month 2 | Month 3 | |
| CBT for POD | 5.75 | 4.15 | 4.08 | 3.22 |
| Educational Counseling for POD | 5.48 | 3.74 | 3.61 | 3.23 |
| Physician Management | 5.01 | 3.32 | 3.45 | 3.87 |
Percentage of doses taken of those prescribed from electronic monitoring. Here we present all data collected at all time points used in analysis. Evaluation of intervention efficacy was performed with repeated measures regression using continuous adherence measurements at all 6 months post-intervention (7th through 12th month post-baseline) and was restricted to those with adherence data at baseline. (NCT03331978)
Timeframe: baseline (pre-treatment) and post-treatment observations at 7, 8, 9, 10, 11, and 12 months post-baseline
| Intervention | percentage of doses taken (Mean) | |||||
|---|---|---|---|---|---|---|
| 7 months post-baseline | 8 months post-baseline | 9 months post-baseline | 10 months post-baseline | 11 months post-baseline | 12 months post-baseline | |
| Control - No Treatment Education | 70.95 | 70.02 | 64.62 | 71.08 | 63.76 | 70.46 |
| Rise - Treatment Education | 68.80 | 72.76 | 72.09 | 71.27 | 69.87 | 70.32 |
Number of Participants who Reported Taking Greater Than or Equal to 75% of Prescribed Dosage, based on electronic monitoring. Here we present all data collected at all time points used in analysis. Evaluation of intervention efficacy was performed with repeated measures regression using adherence measurements at all 6 months post-intervention (7th through 12th month post-baseline) and was restricted to those with adherence data at baseline. (NCT03331978)
Timeframe: baseline (pre-treatment) and post-treatment observations at 7, 8, 9, 10, 11, and 12 months post-baseline
| Intervention | Participants (Count of Participants) | |||||
|---|---|---|---|---|---|---|
| 7 months post-baseline | 8 months post-baseline | 9 months post-baseline | 10 months post-baseline | 11 months post-baseline | 12 months post-baseline | |
| Control - No Treatment Education | 43 | 40 | 38 | 32 | 29 | 28 |
| Rise - Treatment Education | 45 | 44 | 43 | 42 | 40 | 37 |
"Measure is count of participants who slightly agree or strongly agree with either Most people with AIDS are responsible for having their illness or A person with AIDS must have done something wrong and deserves to be punished." (NCT03331978)
Timeframe: baseline (pre-treatment) and post-treatment observations at 7 and 12 months post-baseline
| Intervention | Participants (Count of Participants) | |
|---|---|---|
| 7 months post-baseline | 12 months post-baseline | |
| Control - No Treatment Education | 29 | 26 |
| Rise - Treatment Education | 25 | 15 |
Outcome is mean agreement with 9 HIV-related conspiracy beliefs, each measured on a 5-point scale from 1=Strongly Disagree to 5=Strongly Agree. (NCT03331978)
Timeframe: baseline (pre-treatment) and post-treatment observations at 7 and 12 months post-baseline
| Intervention | score on a scale (Mean) | |
|---|---|---|
| 7 months post-baseline | 12 months post-baseline | |
| Control - No Treatment Education | 2.65 | 2.56 |
| Rise - Treatment Education | 2.62 | 2.41 |
Viral load undetectable per venipuncture or medical records (NCT03331978)
Timeframe: baseline (pre-treatment) and post-treatment observations at 7 and 12 months post-baseline. For 7M, medical records were used if within 90 days of survey completion; for 13 months, medical records were used if within 90 days before or 180 days after survey
| Intervention | Participants (Count of Participants) | |
|---|---|---|
| 7 month post-baseline | 12 month post-baseline | |
| Control - No Treatment Education | 60 | 56 |
| Rise - Treatment Education | 45 | 50 |
6 reviews available for methadone and AIDS Seroconversion
| Article | Year |
|---|---|
[Pharmacokinetic interactions between methadone and antiretroviral medication in HIV positive patients].
Topics: Anti-HIV Agents; HIV Seropositivity; Humans; Methadone; Narcotics; Substance-Related Disorders; Zido | 2002 |
Drug use and HIV/AIDS in China.
Topics: Acquired Immunodeficiency Syndrome; China; Harm Reduction; Heroin; Heroin Dependence; HIV Seropositi | 2006 |
Methadone maintenance treatment: an update.
Topics: Acquired Immunodeficiency Syndrome; Age Factors; Crime; HIV Seropositivity; Humans; Marital Status; | 1995 |
[Do substitution treatments reduce the incidence of human immunodeficiency virus infections in intravenous heroin addicts? Review of pertinent literature].
Topics: Acquired Immunodeficiency Syndrome; Buprenorphine; Codeine; Female; Heroin Dependence; HIV Infection | 1994 |
The effects of methadone on immune function among injecting drug users: a review.
Topics: Antibody Formation; Female; Heroin Dependence; HIV Seropositivity; Humans; Immunity, Cellular; Immun | 1993 |
What do we really know about AIDS control?
Topics: Acquired Immunodeficiency Syndrome; Adult; Behavior Control; Colorado; Confidentiality; Contraceptio | 1989 |
10 trials available for methadone and AIDS Seroconversion
| Article | Year |
|---|---|
Predictors of opiate agonist treatment retention among injection drug users referred from a needle exchange program.
Topics: Adult; AIDS Serodiagnosis; Analgesics, Opioid; Baltimore; Female; HIV Seropositivity; Humans; Male; | 2009 |
Behavioral drug and HIV risk reduction counseling (BDRC) in MMT programs in Wuhan, China: a pilot randomized clinical trial.
Topics: Adult; China; Counseling; Female; Heroin Dependence; HIV Infections; HIV Seropositivity; Humans; Mal | 2011 |
Behavioral drug and HIV risk reduction counseling (BDRC) in MMT programs in Wuhan, China: a pilot randomized clinical trial.
Topics: Adult; China; Counseling; Female; Heroin Dependence; HIV Infections; HIV Seropositivity; Humans; Mal | 2011 |
Behavioral drug and HIV risk reduction counseling (BDRC) in MMT programs in Wuhan, China: a pilot randomized clinical trial.
Topics: Adult; China; Counseling; Female; Heroin Dependence; HIV Infections; HIV Seropositivity; Humans; Mal | 2011 |
Behavioral drug and HIV risk reduction counseling (BDRC) in MMT programs in Wuhan, China: a pilot randomized clinical trial.
Topics: Adult; China; Counseling; Female; Heroin Dependence; HIV Infections; HIV Seropositivity; Humans; Mal | 2011 |
Comparison of antiretroviral adherence questions.
Topics: Anti-HIV Agents; Female; HIV Seropositivity; Humans; Male; Medication Adherence; Methadone; Middle A | 2012 |
Comparison of antiretroviral adherence questions.
Topics: Anti-HIV Agents; Female; HIV Seropositivity; Humans; Male; Medication Adherence; Methadone; Middle A | 2012 |
Comparison of antiretroviral adherence questions.
Topics: Anti-HIV Agents; Female; HIV Seropositivity; Humans; Male; Medication Adherence; Methadone; Middle A | 2012 |
Comparison of antiretroviral adherence questions.
Topics: Anti-HIV Agents; Female; HIV Seropositivity; Humans; Male; Medication Adherence; Methadone; Middle A | 2012 |
Impact of adherence counseling dose on antiretroviral adherence and HIV viral load among HIV-infected methadone maintained drug users.
Topics: Anti-HIV Agents; Cognitive Behavioral Therapy; Directly Observed Therapy; Drug Users; Female; HIV Se | 2012 |
Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection.
Topics: Adult; Cohort Studies; Communicable Diseases; Follow-Up Studies; Hepatitis C; Heroin Dependence; HIV | 2005 |
Controlled trial of prescribed heroin in the treatment of opioid addiction.
Topics: Adult; Counseling; Drug Administration Schedule; Drug Prescriptions; Female; Health Status; Hepatiti | 2006 |
Adherence to zidovudine (AZT) among HIV-infected methadone patients: a pilot study of supervised therapy and dispensing compared to usual care.
Topics: Adult; CD4 Lymphocyte Count; Drug Monitoring; Female; Follow-Up Studies; HIV Seropositivity; Humans; | 1995 |
Drug abuse treatment programs as centers for HIV-related research and treatment.
Topics: Adolescent; Adult; Ethnicity; Female; Health Promotion; HIV Seropositivity; Humans; Information Syst | 1993 |
['Methadone substitution therapy and driving'. Results of an experimental study].
Topics: Adult; Analysis of Variance; Automobile Driver Examination; Automobile Driving; Female; Germany; Her | 1999 |
Effect of fusidic acid on the hepatic cytochrome P450 enzyme system.
Topics: Anti-Bacterial Agents; Antipyrine; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme Sys | 1999 |
141 other studies available for methadone and AIDS Seroconversion
| Article | Year |
|---|---|
A 35-year follow-up study of patients admitted to methadone treatment between 1982-1984 in Asturias, Spain.
Topics: Female; Follow-Up Studies; Hepatitis B; Hepatitis C; Heroin; Heroin Dependence; HIV Seropositivity; | 2023 |
Factors associated with nicotine dependence during methadone maintenance treatment: findings from a multisite survey in Vietnam.
Topics: Adult; Alcohol Drinking; Analgesics, Opioid; Cross-Sectional Studies; Developing Countries; Female; | 2017 |
Participation pattern of methadone users and its association with social connection and HIV status: Analyses of electronic health records data.
Topics: Adult; Algorithms; Case-Control Studies; Electronic Health Records; Female; HIV Infections; HIV Sero | 2019 |
Effectiveness and feasibility study of routine HIV rapid testing in an urban methadone maintenance treatment program.
Topics: Adolescent; Adult; Aged; Ambulatory Care Facilities; Counseling; Feasibility Studies; Female; HIV In | 2013 |
Referring heroin users from compulsory detoxification centers to community methadone maintenance treatment: a comparison of three models.
Topics: Adolescent; Adult; China; Community Health Services; Female; Heroin; Heroin Dependence; HIV Seroposi | 2013 |
[Factors associated with overdose-caused mortality of HIV-positive patients who were on methadone maintenance treatment program].
Topics: Adult; Case-Control Studies; Drug Overdose; Drug Users; HIV Seropositivity; Humans; Male; Methadone; | 2013 |
Proteomic analysis of saliva in HIV-positive heroin addicts reveals proteins correlated with cognition.
Topics: Adult; Cognition; Demography; Enzyme-Linked Immunosorbent Assay; Female; Heat-Shock Proteins; Heroin | 2014 |
[Study on the adherence and related determinants among HIV-positive clients under methadone maintenance treatment in Dali,Yunnan province from 2005 to 2013].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiretroviral Therapy, Highly Active; Child; Child, Pre | 2014 |
[Club-based drug use and its associated risk factors among HIV-positive methadone maintenance treatment clients].
Topics: Adult; China; Female; HIV Seropositivity; Humans; Male; Methadone; Middle Aged; Opiate Substitution | 2014 |
Predictors of accessing antiretroviral therapy among HIV-positive drug users in China's National Methadone Maintenance Treatment Programme.
Topics: Adult; Anti-HIV Agents; China; Cohort Studies; Drug Users; Female; Follow-Up Studies; Health Service | 2015 |
Factors associated with willingness to participate in a pharmacologic addiction treatment clinical trial among people who use drugs.
Topics: Adult; British Columbia; Cocaine-Related Disorders; Cohort Studies; Comorbidity; Crack Cocaine; Fema | 2015 |
Dose-response relationship between methadone dose and adherence to antiretroviral therapy among HIV-positive people who use illicit opioids.
Topics: Adult; Analgesics, Opioid; Anti-HIV Agents; British Columbia; Dose-Response Relationship, Drug; Fema | 2015 |
[Impacts of antiretroviral treatment on drug use and high risk sexual behaviors among HIV-positive MMT clients].
Topics: Anti-HIV Agents; China; Condoms; Cross-Sectional Studies; HIV Infections; HIV Seropositivity; Humans | 2015 |
Association of patterns of methadone use with antiretroviral therapy discontinuation: a prospective cohort study.
Topics: Adult; Anti-Retroviral Agents; Canada; Cohort Studies; Female; HIV Seropositivity; HIV-1; Humans; Ma | 2015 |
Behavioral and quality-of-life outcomes in different service models for methadone maintenance treatment in Vietnam.
Topics: Adult; Cross-Sectional Studies; Delivery of Health Care; Female; HIV Seropositivity; Humans; Male; M | 2016 |
[Overdose of heroin and influencing factors in intravenous drug users in parts of Yunnan].
Topics: China; Drug Overdose; Drug Users; Heroin; Heroin Dependence; HIV Seropositivity; Humans; Logistic Mo | 2016 |
Psychiatric Disorders Among Patients Seeking Treatment for Co-Occurring Chronic Pain and Opioid Use Disorder.
Topics: Adult; Buprenorphine; Chronic Pain; Comorbidity; Cross-Sectional Studies; Disability Evaluation; Fem | 2016 |
Psychiatric Disorders Among Patients Seeking Treatment for Co-Occurring Chronic Pain and Opioid Use Disorder.
Topics: Adult; Buprenorphine; Chronic Pain; Comorbidity; Cross-Sectional Studies; Disability Evaluation; Fem | 2016 |
Psychiatric Disorders Among Patients Seeking Treatment for Co-Occurring Chronic Pain and Opioid Use Disorder.
Topics: Adult; Buprenorphine; Chronic Pain; Comorbidity; Cross-Sectional Studies; Disability Evaluation; Fem | 2016 |
Psychiatric Disorders Among Patients Seeking Treatment for Co-Occurring Chronic Pain and Opioid Use Disorder.
Topics: Adult; Buprenorphine; Chronic Pain; Comorbidity; Cross-Sectional Studies; Disability Evaluation; Fem | 2016 |
Prevalence of problem alcohol use among patients attending primary care for methadone treatment.
Topics: Adult; Alcoholism; Analgesics, Opioid; Cross-Sectional Studies; Female; Hepatitis C; Heroin Dependen | 2009 |
[Study on the time of retention and related influencing factors of patients receiving methadone maintenance treatment in Hunan province].
Topics: Age Factors; China; Follow-Up Studies; HIV Seronegativity; HIV Seropositivity; Humans; Methadone; Ne | 2009 |
Costs of hospital-based methadone maintenance treatment in HIV/AIDS control among injecting drug users in Indonesia.
Topics: Adult; Cost-Benefit Analysis; Female; Heroin Dependence; HIV Seropositivity; Hospital Costs; Humans; | 2010 |
Methadone use among HIV-positive injection drug users in a Canadian setting.
Topics: Adult; Aged; Canada; Cohort Studies; Female; HIV Seropositivity; Humans; Male; Methadone; Middle Age | 2010 |
Crossing over: drug network characteristics and injection risk along the China-Myanmar border.
Topics: Adolescent; Adult; China; Female; HIV Seropositivity; Humans; Internationality; Interpersonal Relati | 2011 |
Clinical characteristics and risk behavior as a function of HIV status among heroin users enrolled in methadone treatment in northern Taiwan.
Topics: Adult; Dose-Response Relationship, Drug; Female; Hepatitis C; Heroin Dependence; HIV Seronegativity; | 2011 |
A high proportion of users of low-threshold facilities with needle exchange programmes in Switzerland are currently on methadone treatment: implications for new approaches in harm reduction and care.
Topics: Adult; Age Factors; Cocaine; Cross-Sectional Studies; Female; Harm Reduction; HIV Seropositivity; Hu | 2012 |
Changes in drug use are associated with health-related quality of life improvements among methadone maintenance patients with HIV/AIDS.
Topics: Adult; Cohort Studies; Female; HIV Infections; HIV Seropositivity; Humans; Longitudinal Studies; Mal | 2012 |
Predictors of the severity of depressive symptoms among intravenous heroin users receiving methadone maintenance treatment in Taiwan: an 18-month follow-up study.
Topics: Adolescent; Adult; Depression; Female; Follow-Up Studies; Heroin Dependence; HIV Seropositivity; Hum | 2012 |
Cost-effectiveness of methadone maintenance treatment for HIV-positive drug users in Vietnam.
Topics: Adult; Cohort Studies; Cost-Benefit Analysis; Female; HIV Infections; HIV Seropositivity; Humans; Ma | 2012 |
Prospective evaluation of bone mineral density among middle-aged HIV-infected and uninfected women: Association between methadone use and bone loss.
Topics: Adult; Age Factors; Body Mass Index; Bone Density; Bone Resorption; Female; Hepatitis C; HIV Infecti | 2011 |
Economic evaluation of methadone maintenance treatment in HIV/AIDS control among injecting drug users in Dehong, China.
Topics: China; Cohort Studies; Cost-Benefit Analysis; Female; HIV Seropositivity; Humans; Male; Methadone; N | 2012 |
[Study on incidence of HIV infection among heroin addicts receiving methadone maintenance treatment in Dehong prefecture, Yunnan province].
Topics: Adolescent; Adult; Aged; China; Drug Users; Female; Heroin Dependence; HIV Infections; HIV Seroposit | 2011 |
Cost-effectiveness of integrating methadone maintenance and antiretroviral treatment for HIV-positive drug users in Vietnam's injection-driven HIV epidemics.
Topics: Adult; Antiretroviral Therapy, Highly Active; Attitude; Cohort Studies; Cost-Benefit Analysis; Drug | 2012 |
Effectiveness of antiretroviral therapy in HIV-1-infected active drug users attended in a drug abuse outpatient treatment facility providing a multidisciplinary care strategy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Cou | 2012 |
Unprotected sex among HIV-positive treatment-seeking opioid-dependent adults in China: a cross-sectional study.
Topics: Adult; China; Cross-Sectional Studies; Female; Government Programs; Health Behavior; Hepatitis C; HI | 2012 |
Substance use and psychotherapeutic medications: a likely contributor to menstrual disorders in women who are seropositive for human immunodeficiency virus.
Topics: Adult; Case-Control Studies; Cohort Studies; Female; HIV Seronegativity; HIV Seropositivity; Humans; | 2003 |
Spiritual beliefs, world assumptions, and HIV risk behavior among heroin and cocaine users.
Topics: Adult; Cocaine-Related Disorders; Culture; Female; Heroin Dependence; HIV Seropositivity; Humans; Ma | 2003 |
Effects of long-term, medically supervised, drug-free treatment and methadone maintenance treatment on drug users' emergency department use and hospitalization.
Topics: Adult; Delivery of Health Care; Emergencies; Female; HIV Infections; HIV Seronegativity; HIV Seropos | 2003 |
HIV-positive injection drug users who leave the hospital against medical advice: the mitigating role of methadone and social support.
Topics: Acquired Immunodeficiency Syndrome; Adult; Female; HIV Seropositivity; Hospitalization; Humans; Male | 2004 |
Characteristics of heroin addicts entering methadone maintenance treatment: quality of life and gender.
Topics: Adult; Comorbidity; Cross-Sectional Studies; Female; Health Status; Heroin Dependence; HIV Seroposit | 2004 |
Knowledge of and interest in hepatitis C treatment at a methadone clinic.
Topics: Adult; Comorbidity; Cross-Sectional Studies; Female; Health Knowledge, Attitudes, Practice; Health S | 2005 |
Methadone maintenance treatment in the Swiss Canton of Vaud: demographic and clinical data on 1,782 ambulatory patients.
Topics: Adult; Ambulatory Care; Catchment Area, Health; Demography; Female; Hepatitis B; Hepatitis B Vaccine | 2005 |
Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenophine substitution.
Topics: Adult; Buprenorphine; Female; HIV Seropositivity; Humans; Infant Care; Infant, Newborn; Methadone; N | 2006 |
Phenomenologies of the akratic self: masculinity, regrets, and HIV among men on methadone.
Topics: Adult; Emotions; Gender Identity; Heterosexuality; HIV Seropositivity; Humans; Intention; Interviews | 2006 |
A social network profile and HIV risk among men on methadone: do social networks matter?
Topics: Adult; HIV Seropositivity; Humans; Interviews as Topic; Male; Methadone; Middle Aged; New York City; | 2006 |
Neuropsychological impairment among asymptomatic HIV-positive former intravenous drug users.
Topics: Adult; Chi-Square Distribution; Heterosexuality; HIV Infections; HIV Seropositivity; Humans; Male; M | 2006 |
[Health related quality of life among HIV-HCV co-infected patients].
Topics: Adult; Anti-Retroviral Agents; Buprenorphine; Cohort Studies; Counseling; Data Interpretation, Stati | 2006 |
Mechanisms of prescription drug diversion among drug-involved club- and street-based populations.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Analgesics, Opioid; Antiretroviral Therapy, Highly | 2007 |
On-site medical care in methadone maintenance: associations with health care use and expenditures.
Topics: Ambulatory Care; Cluster Analysis; Comorbidity; Cost Savings; Delivery of Health Care, Integrated; H | 2007 |
Test-retest reliability of self-reported drug treatment variables.
Topics: Ambulatory Care; Crime; Health Knowledge, Attitudes, Practice; Health Services Accessibility; HIV Se | 2007 |
Two-step tuberculin skin testing in drug users.
Topics: Adult; AIDS-Related Opportunistic Infections; Alcoholism; CD4 Lymphocyte Count; Comorbidity; Female; | 2007 |
Body composition, gender, and illicit drug use in an urban cohort.
Topics: Baltimore; Black People; Body Composition; Body Mass Index; Cocaine-Related Disorders; Comorbidity; | 2007 |
A preliminary study of spiritual self-schema (3-S(+)) therapy for reducing impulsivity in HIV-positive drug users.
Topics: Adult; Buddhism; Cognitive Behavioral Therapy; Female; HIV Seropositivity; Holistic Health; Humans; | 2007 |
Effectiveness of first eight methadone maintenance treatment clinics in China.
Topics: Adult; AIDS Serodiagnosis; China; Crime; Cross-Sectional Studies; Data Collection; Disease Outbreaks | 2007 |
Methadone treatment and risk of HIV infection in drug users without legal access to clean injection equipment.
Topics: Adolescent; Adult; Female; HIV Seropositivity; Humans; Male; Methadone; Needle-Exchange Programs; Ri | 1995 |
T cell counts from "methadone" and "nonmethadone" groups.
Topics: CD4 Lymphocyte Count; HIV Seropositivity; Humans; Methadone; Substance Abuse, Intravenous; T-Lymphoc | 1995 |
The impact on behavior of notifying methadone patients of their HIV serostatus.
Topics: Adult; Attitude to Health; Cocaine; Demography; Female; HIV Seronegativity; HIV Seropositivity; Huma | 1995 |
HIV risk-taking behaviour among injecting drug users currently, previously and never enrolled in methadone treatment.
Topics: Acquired Immunodeficiency Syndrome; Adult; Female; HIV Seropositivity; Humans; Male; Methadone; Midd | 1995 |
HIV-1 incidence determined retrospectively among drug users in Bangkok, Thailand.
Topics: Acquired Immunodeficiency Syndrome; Female; HIV Antibodies; HIV Seropositivity; HIV-1; HIV-2; Humans | 1994 |
Loss and regeneration: influences on the reproductive decisions of HIV positive, drug-using women.
Topics: Adult; Decision Making; Female; HIV Seropositivity; Humans; Infectious Disease Transmission, Vertica | 1994 |
Methadone treatment programmes in the United Kingdom.
Topics: Adult; Drug Prescriptions; Heroin Dependence; HIV Infections; HIV Seropositivity; HIV Seroprevalence | 1994 |
[Value and limitations of substitution treatments in the care of drug addicts].
Topics: Acquired Immunodeficiency Syndrome; Adult; Buprenorphine; France; HIV Infections; HIV Seropositivity | 1994 |
[Complementary prevention actions as a means of reducing risks].
Topics: Acquired Immunodeficiency Syndrome; Female; Hepatitis, Viral, Human; HIV Infections; HIV Seropositiv | 1994 |
The effect of methadone on immunological parameters among HIV-positive and HIV-negative drug users.
Topics: Adult; Animals; CD4 Antigens; CD8 Antigens; Ethnicity; Female; Heroin; HIV Seronegativity; HIV Serop | 1994 |
[The clinical and epidemiological aspects of the neonatal abstinence syndrome].
Topics: Adult; Chi-Square Distribution; Cocaine; Female; Heroin; HIV Seropositivity; Humans; Incidence; Infa | 1993 |
A prospective four-year follow-up of neuropsychological function in HIV seropositive and seronegative methadone-maintained patients.
Topics: Adult; AIDS Dementia Complex; Ambulatory Care; Female; Follow-Up Studies; HIV Seronegativity; HIV Se | 1993 |
Association of immune activation with intravenous heroin use and methadone treatment in HIV-1 seropositive and seronegative subjects.
Topics: Adult; Biopterins; Cross-Sectional Studies; Female; Heroin; HIV Seropositivity; HIV-1; Humans; Immun | 1993 |
[HIV prevention in HIV-positive drug addicts. A methadone-supported model].
Topics: Adult; Female; Health Education; HIV Infections; HIV Seropositivity; Humans; Male; Methadone; Middle | 1993 |
Participation in an outreach-based coupon distribution program for free methadone detoxification.
Topics: Adult; AIDS Serodiagnosis; Amphetamines; Cocaine; Cost Savings; Female; Heroin Dependence; HIV Serop | 1993 |
Re: "The harm reduction approach and risk factors for human immunodeficiency virus (HIV) seroconversion in injecting drug users, Amsterdam".
Topics: Cohort Studies; HIV Seropositivity; Humans; Logistic Models; Methadone; Needle Sharing; Netherlands; | 1993 |
Demographic, medical history and sexual correlates of HIV seropositive methadone maintained women.
Topics: Adolescent; Adult; Black or African American; Blotting, Western; Demography; Ethnicity; Female; Heal | 1993 |
Medical disorders in a cohort of New York city drug abusers: much more than HIV disease.
Topics: Adult; Aged; Blood Chemical Analysis; Female; Health Status; Hepatitis B; HIV Seropositivity; Hospit | 1993 |
Medical maintenance: a pilot study.
Topics: Adult; Female; HIV Seropositivity; Humans; Male; Methadone; Middle Aged; Pilot Projects; Severity of | 1993 |
Methadone-substitution and driving ability.
Topics: Austria; Automobile Driver Examination; Automobile Driving; Drug Monitoring; Evaluation Studies as T | 1993 |
Magnetic resonance abnormalities in HIV infection: a study in the drug-user risk group.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS Dementia Complex; Brain; Brain Diseases; Cognition D | 1993 |
[The medical duty of confidentiality with patients on methadone].
Topics: Adult; Confidentiality; Female; Germany; HIV Seropositivity; HIV-1; Humans; Male; Methadone; Narcoti | 1996 |
Retention in a low-threshold methadone maintenance program.
Topics: Adult; Comorbidity; Dose-Response Relationship, Drug; Female; Heroin Dependence; HIV Seropositivity; | 1996 |
Does HIV test result influence methadone maintenance treatment retention?
Topics: Adult; AIDS Serodiagnosis; Feasibility Studies; Female; HIV Seronegativity; HIV Seropositivity; Huma | 1996 |
Deaths among drug abusers in south-east Scotland (1989-1994).
Topics: Adolescent; Adult; Cause of Death; Drug Overdose; Female; HIV Seropositivity; Humans; Male; Methadon | 1996 |
Integrating primary care and methadone maintenance treatment: implementation issues.
Topics: Adult; Combined Modality Therapy; Comorbidity; Delivery of Health Care, Integrated; Female; HIV Sero | 1997 |
Deaths related to methadone have doubled in Lothian.
Topics: Death, Sudden; HIV Seropositivity; Humans; Methadone; Scotland; Substance Abuse, Intravenous | 1997 |
Who uses needle exchange? A study of injection drug users in treatment in San Francisco, 1989-1990.
Topics: Adolescent; Adult; Female; HIV Infections; HIV Seropositivity; Humans; Ill-Housed Persons; Inactivat | 1997 |
Psychosocial antecedents of needle/syringe disinfection by drug users: a theory-based prospective analysis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Cocaine-Related Disorders; Disinfection; Female; Health E | 1997 |
Truncated recurrent event survival models for methadone data.
Topics: Biometry; Female; Hepatitis C; Heroin Dependence; HIV Seropositivity; Humans; Likelihood Functions; | 1997 |
A preliminary investigation of lamotrigine for cocaine abuse in HIV-seropositive patients.
Topics: Adult; Buprenorphine; Cocaine-Related Disorders; Combined Modality Therapy; Dose-Response Relationsh | 1998 |
Temporal trends in the progression of human immunodeficiency virus disease in a cohort of drug users.
Topics: Acquired Immunodeficiency Syndrome; Adult; Cohort Studies; Disease Progression; Female; Health Servi | 1998 |
Relationship of HIV testing and high-risk behaviors among clients in methadone maintenance treatment.
Topics: Adult; Data Interpretation, Statistical; Depression; Female; Heroin Dependence; HIV Infections; HIV | 1998 |
The impact of methadone on consumption of inpatient care and mortality, with special reference to HIV status.
Topics: Adult; Female; HIV Infections; HIV Seropositivity; Hospitalization; Humans; Length of Stay; Male; Me | 1998 |
Changes in mortality, arrests, and hospitalizations in nonvoluntarily treated heroin addicts in relation to methadone treatment.
Topics: Adult; Cohort Studies; Crime; Female; Heroin Dependence; HIV Infections; HIV Seropositivity; Hospita | 1998 |
Therapeutic drug monitoring of methadone in HIV-infected patients receiving protease inhibitors.
Topics: Adult; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; HIV Protease Inhibitors; HIV S | 1998 |
Correlates of retention on the South Australian Methadone Program 1981-91.
Topics: HIV Seropositivity; Humans; Methadone; Opioid-Related Disorders; Patient Dropouts; Risk Factors; Sou | 1998 |
Personal social networks and HIV status among women on methadone.
Topics: Adult; Female; HIV Seropositivity; Humans; Interpersonal Relations; Methadone; Middle Aged; Multivar | 1998 |
Methadone is poorly removed by haemodialysis.
Topics: Analgesics, Opioid; Biological Availability; Half-Life; HIV Seropositivity; Humans; Kidney Failure, | 1999 |
Induction of antibodies to methadone during methadone maintenance treatment of heroin addicts and its possible clinical implications.
Topics: Adult; Antibodies; Enzyme-Linked Immunosorbent Assay; Female; Heroin Dependence; HIV Seropositivity; | 1999 |
Pre-AIDS mortality and morbidity among injection drug users in Amsterdam and Baltimore: an ecological comparison.
Topics: Adult; Amphetamines; Baltimore; Cause of Death; Cocaine; Cohort Studies; Comorbidity; Cost Control; | 1999 |
Tuberculosis prevention in methadone maintenance clinics. Effectiveness and cost-effectiveness.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Cost-Benefit Analysis; Drug The | 1999 |
Methadone maintenance treatment modalities in relation to incidence of HIV: results of the Amsterdam cohort study.
Topics: Adolescent; Adult; Cohort Studies; Female; HIV Infections; HIV Seropositivity; Humans; Incidence; Ma | 1999 |
The street/treatment barrier: treatment experiences of Puerto Rican injection drug users.
Topics: Adult; Communication Barriers; Community-Institutional Relations; Cultural Characteristics; Female; | 1999 |
Methadone-maintained former heroin addicts, including those who are anti-HIV-1 seropositive, comply with and respond to hepatitis B vaccination.
Topics: Adult; Female; Hepatitis B; Hepatitis B Vaccines; Heroin Dependence; HIV Seropositivity; Humans; Inj | 1999 |
Nevirapine and methadone withdrawal.
Topics: Anti-HIV Agents; Drug Interactions; HIV Seropositivity; Humans; Methadone; Narcotics; Nevirapine; Su | 1999 |
Factors predicting entry of injecting drug users into substance abuse treatment.
Topics: Adolescent; Adult; Comorbidity; Factor Analysis, Statistical; Female; Heroin Dependence; HIV Infecti | 2000 |
[Axillary plexus catheter block in accidental intra-arterial levomethadone HCl injection in an HIV-positive, hepatitis B and C active drug dependent patient].
Topics: Adult; Amides; Anesthetics, Local; Arm; Axillary Artery; Blood Flow Velocity; Brachial Plexus; Cathe | 2000 |
Correlates of enrollment in methadone maintenance treatment programs differ by HIV-serostatus.
Topics: Adult; Baltimore; Cohort Studies; Female; Health Services Accessibility; HIV Antibodies; HIV Infecti | 2000 |
Sex, drugs, and HIV: does methadone maintenance reduce drug use and risky sexual behavior?
Topics: Adult; Condoms; Cross-Sectional Studies; Female; Follow-Up Studies; HIV Seropositivity; Humans; Male | 2000 |
Depressive disorders and personality variables in HIV positive and negative intravenous drug-users.
Topics: Adult; Comorbidity; Depressive Disorder; Female; HIV Seronegativity; HIV Seropositivity; Humans; Ita | 2001 |
How injection drug users coped with testing HIV-seropositive: implications for subsequent health-related behaviors.
Topics: Acquired Immunodeficiency Syndrome; Adaptation, Psychological; Adult; Data Interpretation, Statistic | 2001 |
[Cocaine abuse in maintenance therapy with methadone in narcotic dependent patients].
Topics: Adolescent; Adult; Ambulatory Care; Anti-Anxiety Agents; Austria; Benzodiazepines; Cocaine-Related D | 2001 |
The pharmacokinetics of methadone following co-administration with a lamivudine/zidovudine combination tablet in opiate-dependent subjects.
Topics: Adolescent; Adult; Anti-HIV Agents; Drug Combinations; Female; HIV Seropositivity; Humans; Lamivudin | 2002 |
HIV seroconversion.
Topics: Adult; Heroin Dependence; HIV Seropositivity; Humans; Liver Function Tests; Male; Methadone; Narcoti | 2002 |
HIV prevalence and risk behavior among injecting drug users who participate in "low-threshold" methadone programs in Amsterdam.
Topics: Adolescent; Adult; Confounding Factors, Epidemiologic; Female; Health Behavior; Health Services Rese | 1992 |
Methadone maintenance treatment and HIV type 1 seroconversion among injecting drug users.
Topics: Adult; Connecticut; Female; Health Services Research; HIV Seropositivity; Humans; Male; Methadone; M | 1992 |
A cognitive-existential analysis of counselor responses to HIV-positive substance misusers in an outpatient methadone program and a residential therapeutic community.
Topics: Acquired Immunodeficiency Syndrome; Adult; Ambulatory Care; Attitude to Health; Behavior Therapy; Co | 1992 |
Methadone and immune function.
Topics: CD4-Positive T-Lymphocytes; HIV Seropositivity; Humans; Methadone; Substance Abuse, Intravenous | 1992 |
No seroconversions among steady sex partners of methadone-maintained HIV-1-seropositive injecting drug users in New York City.
Topics: Adult; Female; Follow-Up Studies; HIV Antibodies; HIV Seropositivity; HIV-1; Humans; Longitudinal St | 1992 |
Auditory event-related potentials in HIV-1 infection: a study in the drug-user risk group.
Topics: Adult; AIDS Dementia Complex; Brain Stem; Evoked Potentials, Auditory, Brain Stem; HIV Seropositivit | 1992 |
Two cases of clonidine abuse/dependence in methadone-maintained patients.
Topics: Clonidine; Dose-Response Relationship, Drug; Female; Heroin Dependence; HIV Seropositivity; Humans; | 1992 |
[Methadone maintenance of HIV-infected drug addicts with immune deficiency].
Topics: Acquired Immunodeficiency Syndrome; Adult; Female; Heroin Dependence; HIV Seropositivity; Humans; Ma | 1991 |
Immune function and anti-HTLV-I/II status in anti-HIV-1-negative intravenous drug users receiving methadone.
Topics: Adult; B-Lymphocytes; Deltaretrovirus Antibodies; HIV Antibodies; HIV Seropositivity; Humans; Illici | 1991 |
[Methadone treatment of narcotic addicts--can it be justified?].
Topics: HIV Seropositivity; Humans; Methadone; Opioid-Related Disorders | 1991 |
[Prenatal development and postnatal morbidity of newborn infants of HIV positive mothers].
Topics: Birth Weight; Female; Fetal Growth Retardation; Gestational Age; HIV Seropositivity; Humans; Infant, | 1990 |
Heroin users seeking methadone treatment.
Topics: Adult; Australia; Crime; Female; Heroin Dependence; HIV Seropositivity; Humans; Male; Methadone; Pat | 1990 |
Creating a new drug service in Edinburgh.
Topics: Adult; Community Mental Health Services; Family Practice; Female; HIV Seropositivity; Humans; Male; | 1990 |
[Prevention of HIV infection in the methadone program. A study of a drop-in clinic in Zurich].
Topics: Adult; Female; HIV Seropositivity; HIV Seroprevalence; Humans; Male; Methadone; Retrospective Studie | 1990 |
Zidovudine overdose in an intravenous drug user.
Topics: Adult; Female; HIV Seropositivity; Humans; Methadone; Nervous System Diseases; Substance Abuse, Intr | 1990 |
Absence of antibody to human immunodeficiency virus in long-term, socially rehabilitated methadone maintenance patients.
Topics: Female; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Heroin Depe | 1990 |
Alcohol and immune function in HIV-1 seronegative, HTLV-I/II seronegative and positive men on methadone.
Topics: Adult; Aged; Alcohol Drinking; Cohort Studies; Heroin Dependence; HIV Seropositivity; HIV-1; HTLV-I | 1990 |
[Treatment, care and prevention for HIV-positive intravenous drug addicts].
Topics: Acquired Immunodeficiency Syndrome; Health Education; HIV Seropositivity; Humans; Methadone; New Yor | 1990 |
Reactions of methadone patients to HIV antibody testing.
Topics: Acquired Immunodeficiency Syndrome; Adaptation, Psychological; Adult; AIDS Serodiagnosis; Female; Fo | 1990 |
A prospective comparison of neuropsychologic function in HIV-seropositive and seronegative methadone-maintained patients.
Topics: Adaptation, Psychological; Black or African American; Family; Female; Follow-Up Studies; Hispanic or | 1990 |
Behavioral risk factors of human immunodeficiency virus infection among intravenous drug users and implications for preventive interventions.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Contraceptive Devices, Male; Female; HIV Sero | 1990 |
Links between cocaine and retroviral infection.
Topics: Black or African American; Cocaine; Heroin; Hispanic or Latino; HIV Seropositivity; Humans; Injectio | 1989 |
Suppression of human peripheral blood mononuclear cell function by methadone and morphine.
Topics: Adult; Cells, Cultured; HIV Seropositivity; Humans; In Vitro Techniques; Interferon-gamma; Leukocyte | 1989 |
Mode of HIV transmission among seroconverted intravenous drug users (IVDUs): 1987 and 1988 cohort study.
Topics: Adult; Cohort Studies; Female; HIV Seropositivity; HIV Seroprevalence; Humans; Male; Methadone; New | 1989 |
Intravenous drug users and human immunodeficiency virus testing and counseling.
Topics: HIV Seropositivity; Humans; Injections, Intravenous; Methadone; Needles; Patient Education as Topic; | 1989 |
Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients.
Topics: Adult; Heroin Dependence; HIV Seropositivity; Humans; Injections, Intravenous; Killer Cells, Natural | 1989 |
Low prevalence of human immunodeficiency virus infection in methadone program attenders and pregnant intravenous drug users in the western metropolitan region of Sydney.
Topics: Adult; Australia; Cross-Sectional Studies; Female; HIV Antibodies; HIV Seropositivity; Humans; Male; | 1989 |
HIV screening and counseling for intravenous drug abuse patients. Staff and patient attitudes.
Topics: Adult; Attitude of Health Personnel; Attitude to Health; Counseling; Female; HIV Seropositivity; Hum | 1989 |
Cocaine use and HIV infection in intravenous drug users in San Francisco.
Topics: Black or African American; Cocaine; Endocarditis, Bacterial; Female; Heroin; Hispanic or Latino; HIV | 1989 |
Prospective study of human immunodeficiency virus infection and pregnancy outcomes in intravenous drug users.
Topics: Adult; Female; HIV Seropositivity; Hospitalization; Humans; Injections, Intravenous; Methadone; New | 1989 |
Human immunodeficiency virus seropositivity in intravenous drug users in Ohio.
Topics: Acquired Immunodeficiency Syndrome; Adult; Female; HIV Seropositivity; Humans; Male; Methadone; Ohio | 1989 |
Serologic, immunologic, and clinical features of parenteral drug users from contrasting populations.
Topics: Acquired Immunodeficiency Syndrome; Adult; B-Lymphocytes; Female; HIV Seropositivity; Humans; Inject | 1987 |
Coping with AIDS. The special problems of New York City.
Topics: Acquired Immunodeficiency Syndrome; Health Facility Planning; HIV Seropositivity; Home Care Services | 1987 |
[Treatment of drug addicts with methadone in medical practice-- problems of the treatment of heroin addicts with methadone in view of the HIV epidemic].
Topics: Acquired Immunodeficiency Syndrome; Ambulatory Care Facilities; Diagnosis, Differential; Disposable | 1988 |